Several markers including estrogen receptors (ER), progesterone receptors (PR), human epidermal growth factor receptor 2 (HER2) and Ki67 have been demonstrated to play crucial roles in the treatment of early breast cancer (EBC) (4). This evidence concerns the gene ESR1 and breast cancer.